State Street Corp Esperion Therapeutics, Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 4,504,234 shares of ESPR stock, worth $8.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,504,234

Previous 3,854,314 16.86%

Holding current value

$8.2 Million

Previous $6.36 Million 55.83%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.61 - $3.83 $1.05 Million - $2.49 Million	649,920 Added 16.86%	4,504,234 $9.91 Million
Q3 2024 Nov 14, 2024	BUY	$1.61 - $2.73 $160,681 - $272,459	99,802 Added 2.66%	3,854,314 $6.36 Million
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $5.89 Million - $10.4 Million	3,203,263 Added 581.09%	3,754,512 $8.34 Million
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $338,350 - $505,850	167,500 Added 43.65%	551,249 $1.48 Million
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $59,349 - $250,404	81,300 Added 26.88%	383,749 $1.15 Million
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $1.92 Million - $2.82 Million	-1,600,965 Reduced 84.11%	302,449 $420,000
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $217,693 - $1.09 Million	149,105 Added 8.5%	1,903,414 $3.03 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $1.13 Million - $1.88 Million	221,161 Added 14.43%	1,754,309 $10.9 Million
Q3 2022 Nov 15, 2022	BUY	$5.45 - $8.13 $1.57 Million - $2.35 Million	288,609 Added 23.19%	1,533,148 $10.3 Million
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $1.57 Million - $2.19 Million	328,101 Added 35.8%	1,244,539 $7.92 Million
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $433,996 - $722,460	-129,939 Reduced 12.42%	916,438 $4.25 Million
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $2.26 Million - $5.59 Million	469,096 Added 81.26%	1,046,377 $5.23 Million
Q3 2021 Nov 15, 2021	SELL	$11.34 - $21.37 $19 Million - $35.8 Million	-1,674,913 Reduced 74.37%	577,281 $6.96 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $2.59 Million - $3.84 Million	133,748 Added 6.31%	2,252,194 $47.6 Million
Q1 2021 May 17, 2021	SELL	$25.12 - $36.89 $10.2 Million - $14.9 Million	-404,098 Reduced 16.02%	2,118,446 $59.4 Million
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $17.4 Million - $25.7 Million	719,794 Added 39.93%	2,522,544 $65.6 Million
Q3 2020 Nov 10, 2020	BUY	$31.18 - $52.71 $1.72 Million - $2.9 Million	55,054 Added 3.15%	1,802,750 $67 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $19.3 Million - $32.9 Million	641,079 Added 57.93%	1,747,696 $89.7 Million
Q1 2020 May 11, 2020	BUY	$27.44 - $73.84 $30.4 Million - $81.7 Million	1,106,617 New	1,106,617 $34.9 Million

Others Institutions Holding ESPR

# of Institutions

215

Shares Held

129M

Call Options Held

1.78M

Put Options Held

1.27M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $121M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Esperion Therapeutics, Inc. Transaction History